Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and management
Antonio Ceriello, Doina Catrinoiu, Chanchal Chandramouli, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Extracellular vesicles as human therapeutics: A scoping review of the literature
Clorinda Fusco, Giusy De Rosa, Ilaria Spatocco, et al.
Journal of Extracellular Vesicles (2024) Vol. 13, Iss. 5
Open Access | Times Cited: 26
Predicting and preventing heart failure in type 2 diabetes
Ambarish Pandey, Muhammad Shahzeb Khan, Kershaw V. Patel, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 8, pp. 607-624
Closed Access | Times Cited: 35
Efficacy of modern therapies for heart failure with reduced ejection fraction in specific population subgroups: a systematic review and network meta-analysis
Carlo Lavalle, Marco Valerio Mariani, Paolo Severino, et al.
Cardiorenal Medicine (2024) Vol. 14, Iss. 1, pp. 570-580
Open Access | Times Cited: 12
Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases
Petar Seferović, Walter J. Paulus, Giuseppe Rosano, et al.
European Journal of Heart Failure (2024)
Closed Access | Times Cited: 9
Emerging roles of Galectin-3 in diabetes and diabetes complications: A snapshot
Yànhuá Lǐ, Tian Li, Zhiguang Zhou, et al.
Reviews in Endocrine and Metabolic Disorders (2022) Vol. 23, Iss. 3, pp. 569-577
Open Access | Times Cited: 37
Prediabetes and insulin resistance in a population of patients with heart failure and reduced or preserved ejection fraction but without diabetes, overweight or hypertension
Son Kim Tran, Toan Hoang Ngo, Thắng Nguyễn, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 29
Efficacy and safety profile of SGLT2 inhibitors in the elderly: How is the benefit/risk balance?
André Scheen, Fabrice Bonnet
Diabetes & Metabolism (2023) Vol. 49, Iss. 2, pp. 101419-101419
Open Access | Times Cited: 20
Adropin Predicts Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure
Tetiana A. Berezina, Zeljko Obradovic, Elke Boxhammer, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2231-2231
Open Access | Times Cited: 16
Heart Failure Following Anti-Inflammatory Medications in Patients With Type 2 Diabetes Mellitus
Anders Holt, Jarl Emanuel Strange, Nina Nouhravesh, et al.
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 15, pp. 1459-1470
Open Access | Times Cited: 16
New Mechanisms to Prevent Heart Failure with Preserved Ejection Fraction Using Glucagon-like Peptide-1 Receptor Agonism (GLP-1 RA) in Metabolic Syndrome and in Type 2 Diabetes: A Review
Jorge Jalil, Luigi Gabrielli, María Paz Ocaranza, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4407-4407
Open Access | Times Cited: 7
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries
Anna Norhammar, Johan Bodegård, Jan W. Eriksson, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 7, pp. 1277-1287
Open Access | Times Cited: 25
Anti-α-Glucosidase and Antiglycation Activities of α-Mangostin and New Xanthenone Derivatives: Enzymatic Kinetics and Mechanistic Insights through In Vitro Studies
Francine Medjiofack Djeujo, Valeria Francesconi, Maddalena Gonella, et al.
Molecules (2022) Vol. 27, Iss. 2, pp. 547-547
Open Access | Times Cited: 23
Circulating sphingolipids and relationship to cardiac remodelling before and following a low-energy diet in asymptomatic Type 2 Diabetes
Emer M. Brady, Thong Huy Cao, Alastair J. Moss, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Effect of sodium-glucose cotransporter-2 inhibitors on pulmonary arterial wedge pressure
Paschalis Karakasis, Dimitrios Patoulias, George Giannakoulas, et al.
European Journal of Internal Medicine (2024) Vol. 124, pp. 147-149
Closed Access | Times Cited: 5
Evidence of a bi-directional relationship between heart failure and diabetes: a strategy for the detection of glucose abnormalities and diabetes prevention in patients with heart failure
Paul Valensi
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Racial and ethnic disparities in longitudinal trajectories of hospitalizations in patients diagnosed with heart failure
Matthew E. Dupre, Radha Dhingra, Hanzhang Xu, et al.
American Heart Journal (2025)
Closed Access
6. CARDIO-RENAL PROTECTION IN TYPE 2 DIABETES
Stephen Colagiuri, Antonio Ceriello
Diabetes Research and Clinical Practice (2025), pp. 112150-112150
Closed Access
Microvascular Burden and Incident Heart Failure Among Middle-Aged and Older Adults With Type 1 or Type 2 Diabetes
Fu‐Rong Li, Daniel Nyarko Hukportie, H. J. Yang, et al.
Diabetes Care (2022) Vol. 45, Iss. 12, pp. 2999-3006
Open Access | Times Cited: 19
Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society
Andrea M. Yeung, Jingtong Huang, Ambarish Pandey, et al.
Progress in Cardiovascular Diseases (2023) Vol. 79, pp. 65-79
Open Access | Times Cited: 11
Study of cardiovascular risk in type 2 diabetic patients in the acute phase of the coronavirus infection and post-COVID period on the background of therapy with sodium-glucose cotransporter-2 inhibitors
Наталія Кушнарьова, О.В. Zinych, Анжела Шупрович, et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2025) Vol. 20, Iss. 8, pp. 559-564
Open Access
Assessing the risk of heart failure in type 2 diabetes: a prediction algorithm to sustain the evaluation of NT-proBNP in primary care
Francesco Lapi, Ettore Marconi, Gerardo Medea, et al.
Endocrine (2025)
Closed Access
Early longitudinal changes in left ventricular function and morphology in diabetic pigs: evaluation by 3.0T magnetic resonance imaging
Wei‐Feng Yan, Huayan Xu, Li Jiang, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 9
NT-proBNP point-of-care measurement as a screening tool for heart failure and CVD risk in type 2 diabetes with hypertension
Antonio Ceriello, Nebojša Lalić, Eduard Montanya, et al.
Journal of Diabetes and its Complications (2023) Vol. 37, Iss. 3, pp. 108410-108410
Closed Access | Times Cited: 9
Elevated urine albumin-to-creatinine ratio increases the risk of new-onset heart failure in patients with type 2 diabetes
Jie Tao, Dasen Sang, Libo Zhen, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus
Rania Zekry, Gamal A. Omran, Nashwa M. El-Gharbawy, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top